How Common Are Benign vs. Malignant Throat Tumors?

Benign throat tumors are uncommon. True benign tumors make up 5% or fewer of all laryngeal tumors, making them far less frequent than malignant growths in the same area. However, benign vocal fold lesions like polyps and nodules are quite common, affecting up to 1.7% of the general population depending on the type. The answer depends on what kind of growth you’re asking about.

How Benign and Malignant Throat Tumors Compare

The ratio of benign to malignant tumors in the larynx is roughly 2 to 3, meaning malignant growths are somewhat more common. Some older research places the ratio as wide as 1 to 10, with cancerous tumors dominating. Either way, when a true tumor (not a polyp or nodule) is found in the throat, the odds lean toward it being malignant rather than benign. This is one reason any persistent throat growth gets a biopsy.

Common Benign Vocal Fold Lesions

The growths people encounter most often aren’t true tumors at all. They’re reactive lesions, meaning the body produces them in response to irritation, strain, or injury. Vocal nodules are the most prevalent benign laryngeal lesion, found in roughly 1.0% to 1.7% of the population. Vocal fold polyps come second, affecting about 0.3% to 0.6%. These numbers may seem small, but among people who use their voice heavily, like teachers, singers, coaches, and call center workers, the rates are significantly higher.

Polyps show a clear gender split. Men develop them roughly twice as often as women, with most cases appearing between the ages of 17 and 59. One study found 71.3% of polyp patients were male, with an average age of about 42. The leading theory is that vocal strain combined with smoking and acid reflux creates the conditions for polyps to form, and men are more likely to have that combination of risk factors.

Types of True Benign Throat Tumors

When doctors refer to true benign tumors of the throat, they mean growths of abnormal but noncancerous tissue. The main types include papillomas, hemangiomas, fibromas, chondromas (tumors of cartilage), myxomas (tumors of connective tissue), and neurofibromas (tumors of nerve tissue). Of these, papillomas are the most common by a wide margin.

Rarer types are genuinely rare. Adult laryngeal hemangiomas, for example, are so uncommon that only seven cases of the vocal cord variety have been reported in the medical literature. Chondromas and neurofibromas surface occasionally but remain unusual findings. Fibromas and myxomas fall somewhere in between, encountered infrequently in clinical practice but not as exceptional as hemangiomas.

Papillomas and Respiratory Papillomatosis

Papillomas are the most frequent true benign tumor of the larynx. They’re caused by human papillomavirus (HPV), typically types 6 and 11. When papillomas keep growing back after removal, the condition is called recurrent respiratory papillomatosis, or RRP. It occurs in both children and adults, though the childhood form tends to be more aggressive.

In children, the incidence of RRP has dropped substantially thanks to HPV vaccination. New diagnoses fell from about 20 per million children in 2007 to roughly 8 per million in 2022. States with higher vaccination rates saw steeper declines than states with lower rates, reinforcing the link between vaccination and prevention. The drop accelerated after 2014, likely reflecting the growing number of vaccinated parents who no longer passed the virus to their children during birth.

Leukoplakia and the Risk of Cancer

Leukoplakia, a white patch on the throat lining, is technically classified among benign laryngeal lesions. But it deserves special attention because it carries a real risk of turning cancerous. That risk is substantially higher in the throat than in the mouth.

A study tracking 253 patients with leukoplakia found a 10-year malignant transformation rate of 42% for laryngeal leukoplakia, compared to 15.1% for the oral form. Among laryngeal leukoplakia patients whose biopsies showed abnormal cell changes (dysplasia), 80% eventually developed cancer. Without those cell changes, the rate was 11.1%. This is why any white patch found in the throat gets biopsied and monitored closely, even though the lesion itself is not yet cancerous.

Who Gets Benign Throat Growths

Age and gender patterns vary by tumor type. For benign oral and throat mucosal tumors broadly, the gender split is roughly equal, and the age range spans from infancy to the mid-80s with an average around 50. But specific types cluster differently. Tumors arising from nerve tissue and fibrous tissue tend to appear in people under 40, while fatty tumors, vascular tumors, and salivary gland tumors show up more often in people between 54 and 63.

Vocal polyps and nodules follow their own pattern, skewing younger and more male. The most common profile for a polyp patient is a man in his 40s, while nodules are especially prevalent among women who use their voices professionally.

Recurrence After Treatment

Most benign vocal fold lesions are treated with surgery, sometimes combined with voice therapy, steroid injections, or reflux medication. A systematic review covering over 1,000 patients found an average recurrence rate of 13% across all lesion types, including polyps, nodules, cysts, and others.

The details matter, though. Patients who received additional therapies alongside surgery, such as voice therapy or reflux treatment, had a recurrence rate of just 7.1%. Those who had surgery alone saw recurrence rates of 24.4%, more than three times higher. This suggests that surgery fixes the immediate problem, but addressing the underlying causes (vocal strain, acid reflux, smoking) is what keeps the growth from coming back.

Papillomas are the exception to the general picture. RRP is defined by its tendency to recur, and many patients undergo dozens of surgical procedures over their lifetime to keep the airway clear. For this reason, papillomatosis is managed rather than cured in most cases.